RAC 2.20% $1.78 race oncology ltd

Apologies if this has already been shared or if it is not...

  1. 96 Posts.
    lightbulb Created with Sketch. 62
    Apologies if this has already been shared or if it is not relevant, but has anyone else come across this post on LinkedIn?

    Its a plea from someone to find a clinical trial for their brother who has relapsed extra medullary AML.

    The post explains that his isolated extra medullary relapse is an exclusion criteria in many clinical trials.

    Those of you who have a line to Dr T could perhaps share this with him?


    https://www.linkedin.com/posts/marine-tullet-699b6b81_leukemia-clinicaltrials-bloodcancer-activity-7011654157812006912-IZ7W?utm_source=share&utm_medium=member_android






 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.